MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2020

    Cerebral microvascular injury provoked by alpha-synuclein preformed fibrils exacerbates cognitive dysfunction in Parkinson’s disease

    Q.X Zhang, Y.Y Gao, L.J Wang (Guangzhou, China)

    Objective: The aim of this study was to investigate the role of microvascular pathology between abnormal αSyn aggregation and PD cognitive dysfunction. Background: Higher plasma…
  • MDS Virtual Congress 2020

    Retinal thinning and disease worsening in Lewy body diseases

    A. Murueta-Goyena, R. Del Pino, M. Galdós, B. Arana, M. Acera, MM. Carmona-Abellán, P. Reyero, B. Tijero, O. Lucas-Jiménez, N. Ibarretxe-Bilbao, N. Ojeda, J. Peña, J.C Gómez-Esteban, I. Gabilondo (Barakaldo, Spain)

    Objective: To assess longitudinal changes of retinal thickness measurements and their role as biomarkers of disease progression in patients with Lewy body diseases (LBDs). Background:…
  • MDS Virtual Congress 2020

    Profiling Atypical Anxiety in Parkinson’s Disease

    E. Forbes, G. Byrne, J. O'Sullivan, J. Yang, N. Dissanayaka (St Lucia, Australia)

    Objective: We aimed to identify the demographic, psychiatric, clinical and cognitive characteristics associated with Anxiety not otherwise specified (NOS) in persons with Parkinson’s disease (PWP).…
  • MDS Virtual Congress 2020

    Subacute cognitive decline after DBS in a patient with idiopathic delayed-onset edema

    T. De Santis, S. Lalli, D. Calandrella, A. Cocco, M. Di Giovanni, P. Amami, A. Ampollini, F. Motta, E. Mailland, L. Politi, M. Egidi, A. Albanese (Rozzano, Italy)

    Objective: To describe a patient who developed idiopathic delayed-onset edema (IDE) and cognitive decline three days after deep brain stimulation of subthalamic nucleus (STN-DBS). Background: IDE…
  • MDS Virtual Congress 2020

    Pesticide Exposure in PD with and without Genetic Risk Variants

    E. Brown, C. Meng, S. Goldman, C. Tanner (San Francisco, CA, USA)

    Objective: To evaluate the association between pesticide exposure and development of Parkinson’s disease (PD) in idiopathic and genetic PD, and to determine whether clinical features…
  • MDS Virtual Congress 2020

    The role of low contrast visual acuity in cognitive performance in Lewy body diseases

    R. Del Pino, M. Acera, A. Murueta-Goyena, O. Lucas-Jiménez, N. Ojeda, N. Ibarretxe-Bilbao, J. Peña, P. Reyero, J. Cortés, B. Tijero, M. Galdós, J.C Gómez-Esteban, I. Gabilondo (Barakaldo, Spain)

    Objective: We aimed to quantify the role and the association that visual disability has on the neuropsychological performance of patients with Lewy body diseases (LBD).…
  • MDS Virtual Congress 2020

    Impact of Obstructive Sleep Apnea on Cognitive and Motor Functions in Parkinson’s Disease Patients

    M. Elfil, E. Bahbah, M. Eldokmak, M. Attia, B. Koo (New Haven, CT, USA)

    Objective: We conducted this systematic review and meta-analysis to assess the impact of OSA on cognitive and motor disorders in PD patients. Background: Parkinson’s disease…
  • MDS Virtual Congress 2020

    Driving in Parkinson’s Disease: A Retrospective Study of Driving and Mobility Assessments

    K. Lloyd, D. Gaunt, V. Haunton, R. Skelly, H. Mann, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: To describe the characteristics of PD patients assessed at a Driving Mobility Centre and investigate factors that predict driving assessment outcome. Background: To guide…
  • MDS Virtual Congress 2020

    Information processing components in Parkinson’s disease with and without impulse control disorders: identification of diagnostic and predisposition markers

    S.. Cantarero Duque, J.P Romero (Madrid, Spain)

    Objective: To search for differences in specific components of cognitive processing in Parkinson’s disease (PD) patients with and without impulse control disorders (ICD) in order…
  • MDS Virtual Congress 2020

    Diagnostic utility of cerebrospinal fluid t-tau/p-tau181 in Parkinson’s disease with mild cognitive impairment: A cross-sectional study in Chinese cohort

    P. Zhang, Y. Li, L.J Wang, Y.H Zhang (Guangzhou, China)

    Objective: This study explores the value of α-Syn, Aβ1-42, t-tau, p-tau181 in cerebrospinal fluid(CSF) and their ratios for the diagnosis of Parkinson's disease with mild…
  • « Previous Page
  • 1
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley